Revision history of "Molecular tools for prognostic analysis and identification of new therapeutic targets in non-small cell lung carcinoma" (Q3209276)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

10 October 2024

  • curprev 21:5021:50, 10 October 2024DG Regio talk contribs 76,686 bytes 0 Changed label, description and/or aliases in pt
  • curprev 21:5021:50, 10 October 2024DG Regio talk contribs 76,686 bytes +19 Set a claim value: summary (P836): O cancro do pulmão de células não pequenas (CPCNP) representa um grande desafio para o medicamento atual, uma vez que a sua taxa de mortalidade continua a ser extremamente elevada. Para os doentes com estadios iniciais (I e II), a necessidade clínica reside na identificação dos doentes que poderiam beneficiar de terapêuticas adjuvantes. O objetivo deste trabalho é a validação e otimização de assinaturas prognósticas geradas por nós no âmbito do proj...

7 March 2024

21 December 2023

12 June 2023

10 June 2023

18 August 2022

  • curprev 12:0512:05, 18 August 2022DG Regio talk contribs 75,392 bytes +51,688 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

5 December 2021

14 October 2021

  • curprev 09:3009:30, 14 October 2021DG Regio talk contribs 12,745 bytes +178 Changed label, description and/or aliases in en: translated_label
  • curprev 09:3009:30, 14 October 2021DG Regio talk contribs 12,567 bytes +2,367 Created claim: summary (P836): Non-small cell lung cancer (NSCLC) represents a major challenge for today’s medicine, as its mortality rate remains extremely high. For patients with early stages (I and II), the clinical need lies in identifying those patients who could benefit from adjuvant therapies. The objective of this work is the validation and optimisation of prognostic signatures generated by us in the scope of the FIS project that is now concluded (PI10/166). To do th...

11 October 2021

10 October 2021

9 October 2021